Search Count: 93
![]() |
Solution Nmr Structure Of 9-Residue Rosetta-Designed Cyclic Peptide D9.16 In D6-Dmso With Cis/Trans Switching
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 8-Residue Rosetta-Designed Cyclic Peptide D8.31 In D6-Dmso With Cis/Trans Switching (A-Cc Conformation)
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 8-Residue Rosetta-Designed Cyclic Peptide D8.21 In D6-Dmso With Cis/Trans Switching
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 8-Residue Rosetta-Designed Cyclic Peptide D8.21 In 50% D6-Dmso And 50% Water With Cis/Trans Switching (Cc Conformation, 50%)
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 9-Residue Rosetta-Designed Cyclic Peptide D9.16 In Cdcl3 With Cis/Trans Switching (A-Tt Conformation)
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 8-Residue Rosetta-Designed Cyclic Peptide D8.31 In Cdcl3 With Cis/Trans Switching
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 8-Residue Rosetta-Designed Cyclic Peptide D8.21 In Cdcl3 With Cis/Trans Switching (Tt Conformation, 47%)
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:0.85 Å Release Date: 2022-09-14 Classification: DE NOVO PROTEIN Ligands: HOH |
![]() |
Solution Nmr Structure Of 9-Residue Rosetta-Designed Cyclic Peptide D9.16 In Cdcl3 With Cis/Trans Switching (B-Tc Conformation)
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 8-Residue Rosetta-Designed Cyclic Peptide D8.31 In D6-Dmso With Cis/Trans Switching (B-Ct Conformation)
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 8-Residue Rosetta-Designed Cyclic Peptide D8.21 In 50% D6-Dmso And 50% Water With Cis/Trans Switching (Cc Conformation, 50%)
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Solution Nmr Structure Of 8-Residue Rosetta-Designed Cyclic Peptide D8.21 In Cdcl3 With Cis/Trans Switching (Tc Conformation, 53%)
Organism: Synthetic construct
Method: SOLUTION NMR Release Date: 2022-09-14 Classification: DE NOVO PROTEIN |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2022-05-11 Classification: TRANSFERASE Ligands: 86E |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2022-02-09 Classification: IMMUNE SYSTEM Ligands: X5D |
![]() |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2022-01-12 Classification: PROTEIN FIBRIL |
![]() |
Structure Of Egfr_D770_N771Insnpg/V948R In Complex With Covalent Inhibitor Osimertinib.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2021-09-22 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: Q6K, EDO, CIT |
![]() |
Organism: Plasmodium falciparum (isolate 3d7), Plasmodium falciparum
Method: ELECTRON MICROSCOPY Release Date: 2021-09-22 Classification: HYDROLASE Ligands: BO2 |
![]() |
Organism: Plasmodium falciparum (isolate 3d7)
Method: ELECTRON MICROSCOPY Release Date: 2021-09-22 Classification: HYDROLASE Ligands: YHD |
![]() |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-09-22 Classification: HYDROLASE Ligands: YHD |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2021-06-02 Classification: IMMUNE SYSTEM Ligands: X5J |